Cargando…
Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season
In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65–79-year-olds and 13% (95% CI: −15 to 30) among those ≥ 80 years. As the A(H3N2)...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Centre for Disease Prevention and Control (ECDC)
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710120/ https://www.ncbi.nlm.nih.gov/pubmed/29043961 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645 |
_version_ | 1783282917688999936 |
---|---|
author | Rondy, Marc Gherasim, Alin Casado, Itziar Launay, Odile Rizzo, Caterina Pitigoi, Daniela Mickiene, Aukse Marbus, Sierk D Machado, Ausenda Syrjänen, Ritva K Pem-Novose, Iva Horváth, Judith Krisztina Larrauri, Amparo Castilla, Jesús Vanhems, Philippe Alfonsi, Valeria Ivanciuc, Alina E Kuliese, Monika van Gageldonk-Lafeber, Rianne Gomez, Veronica Ikonen, Niina Lovric, Zvjezdana Ferenczi, Annamária Moren, Alain |
author_facet | Rondy, Marc Gherasim, Alin Casado, Itziar Launay, Odile Rizzo, Caterina Pitigoi, Daniela Mickiene, Aukse Marbus, Sierk D Machado, Ausenda Syrjänen, Ritva K Pem-Novose, Iva Horváth, Judith Krisztina Larrauri, Amparo Castilla, Jesús Vanhems, Philippe Alfonsi, Valeria Ivanciuc, Alina E Kuliese, Monika van Gageldonk-Lafeber, Rianne Gomez, Veronica Ikonen, Niina Lovric, Zvjezdana Ferenczi, Annamária Moren, Alain |
author_sort | Rondy, Marc |
collection | PubMed |
description | In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65–79-year-olds and 13% (95% CI: −15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate. |
format | Online Article Text |
id | pubmed-5710120 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | European Centre for Disease Prevention and Control (ECDC) |
record_format | MEDLINE/PubMed |
spelling | pubmed-57101202017-12-08 Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season Rondy, Marc Gherasim, Alin Casado, Itziar Launay, Odile Rizzo, Caterina Pitigoi, Daniela Mickiene, Aukse Marbus, Sierk D Machado, Ausenda Syrjänen, Ritva K Pem-Novose, Iva Horváth, Judith Krisztina Larrauri, Amparo Castilla, Jesús Vanhems, Philippe Alfonsi, Valeria Ivanciuc, Alina E Kuliese, Monika van Gageldonk-Lafeber, Rianne Gomez, Veronica Ikonen, Niina Lovric, Zvjezdana Ferenczi, Annamária Moren, Alain Euro Surveill Rapid Communication In a multicentre European hospital study we measured influenza vaccine effectiveness (IVE) against A(H3N2) in 2016/17. Adjusted IVE was 17% (95% confidence interval (CI): 1 to 31) overall; 25% (95% CI: 2 to 43) among 65–79-year-olds and 13% (95% CI: −15 to 30) among those ≥ 80 years. As the A(H3N2) vaccine component has not changed for 2017/18, physicians and public health experts should be aware that IVE could be low where A(H3N2) viruses predominate. European Centre for Disease Prevention and Control (ECDC) 2017-10-12 /pmc/articles/PMC5710120/ /pubmed/29043961 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645 Text en This article is copyright of The Authors, 2017. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made. |
spellingShingle | Rapid Communication Rondy, Marc Gherasim, Alin Casado, Itziar Launay, Odile Rizzo, Caterina Pitigoi, Daniela Mickiene, Aukse Marbus, Sierk D Machado, Ausenda Syrjänen, Ritva K Pem-Novose, Iva Horváth, Judith Krisztina Larrauri, Amparo Castilla, Jesús Vanhems, Philippe Alfonsi, Valeria Ivanciuc, Alina E Kuliese, Monika van Gageldonk-Lafeber, Rianne Gomez, Veronica Ikonen, Niina Lovric, Zvjezdana Ferenczi, Annamária Moren, Alain Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season |
title | Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season |
title_full | Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season |
title_fullStr | Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season |
title_full_unstemmed | Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season |
title_short | Low 2016/17 season vaccine effectiveness against hospitalised influenza A(H3N2) among elderly: awareness warranted for 2017/18 season |
title_sort | low 2016/17 season vaccine effectiveness against hospitalised influenza a(h3n2) among elderly: awareness warranted for 2017/18 season |
topic | Rapid Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5710120/ https://www.ncbi.nlm.nih.gov/pubmed/29043961 http://dx.doi.org/10.2807/1560-7917.ES.2017.22.41.17-00645 |
work_keys_str_mv | AT rondymarc low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT gherasimalin low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT casadoitziar low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT launayodile low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT rizzocaterina low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT pitigoidaniela low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT mickieneaukse low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT marbussierkd low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT machadoausenda low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT syrjanenritvak low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT pemnovoseiva low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT horvathjudithkrisztina low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT larrauriamparo low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT castillajesus low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT vanhemsphilippe low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT alfonsivaleria low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT ivanciucalinae low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT kuliesemonika low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT vangageldonklafeberrianne low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT gomezveronica low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT ikonenniina low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT lovriczvjezdana low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT ferencziannamaria low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season AT morenalain low201617seasonvaccineeffectivenessagainsthospitalisedinfluenzaah3n2amongelderlyawarenesswarrantedfor201718season |